Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanan Munitz

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Psychiatry Research|August 29, 2017
Cancer prevalence in Israeli men and women with schizophreniaNirit Agay, Natalie Flaks-Manov, Uri Nitzan, et al.
The Annals of Pharmacotherapy|July 31, 2008
Antipsychotics and diabetes: an age-related associationAriel Hammerman, Jacob Dreiher, Shmuel H Klang, et al.
Journal of Clinical Psychopharmacology|May 15, 2002
High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndromeHaggai Hermesh, Iris Manor, Roni Shiloh, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2002
Increased corneal temperature in drug-free male schizophrenia patientsRoni Shiloh, Shirley Portuguese, Liron Bodinger, et al.
International Journal of Adolescent Medicine and Health|July 23, 2004
Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescentsGil Zalsman, Rachel Lewis, Shai Konas, et al.
Neuropsychobiology|July 30, 2003
Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patientsRoni Shiloh, Liron Bodinger, Nachum Katz, et al.
International Clinical Psychopharmacology|April 19, 2003
Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatientsRoni Shiloh, Avi Valevski, Liron Bodinger, et al.
Social Psychiatry and Psychiatric Epidemiology|January 5, 2013
Mental disorders in primary care in Israel: prevalence and risk factorsNeil Laufer, Nelly Zilber, Pablo Jecsmien, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 17, 2008
In vivo occipital-frontal temperature-gradient in schizophrenia patients and its possible association with psychopathology: a magnetic resonance spectroscopy studyRoni Shiloh, Tammar Kushnir, Yaron Gilat, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2009
Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatientsRoni Shiloh, Lior Schapir, Danit Bar-Ziv, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Psychiatry Research|August 29, 2017
Cancer prevalence in Israeli men and women with schizophreniaNirit Agay, Natalie Flaks-Manov, Uri Nitzan, et al.
The Annals of Pharmacotherapy|July 31, 2008
Antipsychotics and diabetes: an age-related associationAriel Hammerman, Jacob Dreiher, Shmuel H Klang, et al.
Journal of Clinical Psychopharmacology|May 15, 2002
High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndromeHaggai Hermesh, Iris Manor, Roni Shiloh, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2002
Increased corneal temperature in drug-free male schizophrenia patientsRoni Shiloh, Shirley Portuguese, Liron Bodinger, et al.
International Journal of Adolescent Medicine and Health|July 23, 2004
Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescentsGil Zalsman, Rachel Lewis, Shai Konas, et al.
Neuropsychobiology|July 30, 2003
Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patientsRoni Shiloh, Liron Bodinger, Nachum Katz, et al.
International Clinical Psychopharmacology|April 19, 2003
Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatientsRoni Shiloh, Avi Valevski, Liron Bodinger, et al.
Social Psychiatry and Psychiatric Epidemiology|January 5, 2013
Mental disorders in primary care in Israel: prevalence and risk factorsNeil Laufer, Nelly Zilber, Pablo Jecsmien, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 17, 2008
In vivo occipital-frontal temperature-gradient in schizophrenia patients and its possible association with psychopathology: a magnetic resonance spectroscopy studyRoni Shiloh, Tammar Kushnir, Yaron Gilat, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2009
Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatientsRoni Shiloh, Lior Schapir, Danit Bar-Ziv, et al.
Pageof 3